Literature DB >> 5943693

Ankylosing spondylitis: a late re-evaluation of 92 cases.

T D Kinsella, R F MacDonald, L G Johnson.   

Abstract

Ninety-two patients who satisfied the criteria proposed by Kellgren for the diagnosis of ankylosing spondylitis were re-evaluated by clinical, radiological and laboratory parameters after an average length of illness of 18.7 years. The following associated clinical lesions were studied: aortic insufficiency 8%, heart block 3%, iritis 11%, and other associated lesions. Long-term effects of x-ray therapy were evaluated by comparing irradiated and non-irradiated patients; no significant difference was noted in the clinical course of these two treatment groups. On serum protein electrophoresis no characteristic dysproteinemia was demonstrated; in no instance was there a marked hypergammaglobulinemia. Test results for rheumatoid factor, antinuclear factor and antithyroglobulin were all within the range expected for a normal population. In addition to bilateral sacroiliitis, several other characteristic radiological lesions, such as anterior spondylitis, were present in a high percentage of cases. It is suggested that the diagnostic criteria proposed by Kellgren, although useful, should be enlarged and refined.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5943693      PMCID: PMC1935552     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  16 in total

1.  ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE.

Authors:  D J WARD; G D JOHNSON; E J HOLBOROW
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

2.  ARTHRITIS MUTILANS AND PSORIASIS.

Authors:  D N GOLDING; H BAKER; M THOMPSON
Journal:  Ann Phys Med       Date:  1963-11

3.  The treatment of ankylosing spondylitis.

Authors:  F D HART
Journal:  Proc R Soc Med       Date:  1955-03

4.  Diagnostic criteria for population studies.

Authors:  J H KELLGREN
Journal:  Bull Rheum Dis       Date:  1962-11

5.  Psoriasis and arthritis.

Authors:  H BAKER; D N GOLDING; M THOMPSON
Journal:  Ann Intern Med       Date:  1963-06       Impact factor: 25.391

6.  Ankylosing spondylitis.

Authors:  D C GRAHAM
Journal:  Can Med Assoc J       Date:  1960-03-26       Impact factor: 8.262

7.  Aortitis and aortic regurgitation associated with rheumatoid spondylitis.

Authors:  E C TOONE; E L PIERCE; G R HENNIGAR
Journal:  Am J Med       Date:  1959-02       Impact factor: 4.965

8.  Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases.

Authors:  M WILKINSON; E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1958-06       Impact factor: 19.103

9.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors:  C M PLOTZ; J M SINGER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

10.  Treatment of ankylosing spondylitis with phenylbutazone (butazolidin).

Authors:  S E FURBER
Journal:  Rheumatism       Date:  1959-07
View more
  8 in total

1.  Differences in cardiovascular manifestations between ankylosing spondylitis patients with and without kyphosis.

Authors:  Jun Fu; Manyan Wu; Yan Liang; Kai Song; Ming Ni; Yonggang Zhang; Jiying Chen
Journal:  Clin Rheumatol       Date:  2016-06-07       Impact factor: 2.980

2.  Cardiovascular manifestations of ankylosing spondylitis.

Authors:  T D Kinsella; L G Johnson; R Ian
Journal:  Can Med Assoc J       Date:  1974-12-21       Impact factor: 8.262

3.  Synovial fluid in ankylosing spondylitis.

Authors:  M J Kendall; M Farr; M J Meynell; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

4.  Aortic incompetence associated with ulcerative colitis and ankylosing spondylitis.

Authors:  G O Cowan; W O'Brien
Journal:  Proc R Soc Med       Date:  1970-01

5.  Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population?

Authors:  Florian Brunner; Andres Kunz; Ulrich Weber; Rudolf Kissling
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

6.  Evaluation of indomethacin by a controlled, cross-over technique in 30 patients with ankylosing spondylitis.

Authors:  T D Kinsella; K R MacKenzie; S O Kim; L G Johnson
Journal:  Can Med Assoc J       Date:  1967-06-03       Impact factor: 8.262

7.  Cardiovascular manifestations of ankylosing spondylitis.

Authors:  S Sukenik; A Pras; D Buskila; A Katz; Y Snir; J Horowitz
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

8.  Modifiable cardiovascular risk factors in patients with ankylosing spondylitis.

Authors:  Björn Sundström; Gunnar Johansson; Ingegerd Johansson; Solveig Wållberg-Jonsson
Journal:  Clin Rheumatol       Date:  2013-10-19       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.